Investigating the role of Levosimendan (a drug which improves the performance of the heart) on patients with heart disease
Phase 3
- Conditions
- Health Condition 1: null- Coronary artery disease
- Registration Number
- CTRI/2014/10/005149
- Lead Sponsor
- Institute Research Grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Coronary artery disease with diastolic dysfunction undregoing coronary artery bypass grafting
Exclusion Criteria
Patients in cardiogenic shock, in sepsis, in renal/hepatic/respiratory failure, not willing to be part of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method